Evidence map›Paper›PMID 39817721›Full record

ArticleeLife2025

Exploration of the metabolomic mechanisms of postmenopausal hypertension induced by low estrogen state.

Yao Li, Hui Xin, Zhexun Lian, Wei Zhang

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yao LiDepartment of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Hui XinDepartment of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zhexun LianDepartment of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Wei ZhangDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.ORCID https://orcid.org/0000-0002-3167-0002

Funding

Natural Science Foundation of Qingdao Municipality 24-4-4-zrjj-105-jchNatural Science Foundation of Shandong Province ZR2024QH262Natural Science Foundation of Shandong Province ZR2024QH640The youth research found of the affiliated hospital of Qingdao university QDFYQN2023111The youth research found of the affiliated hospital of Qingdao university QDFYQN2023119
6 · The paper itself

Abstract

Estrogen significantly impacts women's health, and postmenopausal hypertension is a common issue characterized by blood pressure fluctuations. Current control strategies for this condition are limited in efficacy, necessitating further research into the underlying mechanisms. Although metabolomics has been applied to study various diseases, its use in understanding postmenopausal hypertension is scarce. Therefore, an ovariectomized rat model was used to simulate postmenopausal conditions. Estrogen levels, blood pressure, and aortic tissue metabolomics were analyzed. Animal models were divided into Sham, OVX, and OVX +E groups. Serum estrogen levels, blood pressure measurements, and aortic tissue metabolomics analyses were performed using radioimmunoassay, UHPLC-Q-TOF, and bioinformatics techniques. Based on the above research content, we successfully established a correlation between low estrogen levels and postmenopausal hypertension in rats. Notable differences in blood pressure parameters and aortic tissue metabolites were observed across the experimental groups. Specifically, metabolites that were differentially expressed, particularly L-alpha-aminobutyric acid (L-AABA), showed potential as a biomarker for postmenopausal hypertension, potentially exerting a protective function through macrophage activation and vascular remodeling. Enrichment analysis revealed alterations in sugar metabolism pathways, such as the Warburg effect and glycolysis, indicating their involvement in postmenopausal hypertension. Overall, this current research provides insights into the metabolic changes associated with postmenopausal hypertension, highlighting the role of L-AABA and sugar metabolism reprogramming in aortic tissue. The findings suggest a potential link between low estrogen levels, macrophage function, and vascular remodeling in the pathogenesis of postmenopausal hypertension. Further investigations are needed to validate these findings and explore their clinical implications for postmenopausal women.

Indexed as

EstrogensHypertensionMetabolomePostmenopauseAnimalsAortaBiomarkersBlood PressureDisease Models, AnimalFemaleMetabolomicsOvariectomyRatsRats, Sprague-DawleyBiomarkersEstrogenscarbohydrate metabolismmedicinepostmenopausal hypertensionratvascular remodeling

Identifiers

PMID39817721
PMCPMC11737871

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.